0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Month in Archives of Dermatology |

This Month in Archives of Dermatology FREE

[+] Author Affiliations

Section Editor: Robin L. Travers, MD


Arch Dermatol. 2011;147(4):382. doi:10.1001/archdermatol.2011.61.
Text Size: A A A
Published online

THE USE OF B VITAMINS FOR CUTANEOUS ULCERATIONS MIMICKING PYODERMA GANGRENOSUM IN PATIENTS WITH MTHFR POLYMORPHISM

Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in folate and homocysteine metabolism. Genetic polymorphisms are associated with thrombophilia and vasculopathy, which result in cutaneous ulceration. In this case series, New et al describe 2 patients who were found to have MTHFR polymorphisms during hypercoagulable evaluation for cutaneous ulceration on the lower extremities. Both patients showed rapid improvement following oral B-vitamin supplementation and local wound care. MTHFR polymorphisms should be part of a comprehensive laboratory evaluation when performing a hypercoagulable workup.

ISOLATED CONJUNCTIVAL LICHEN PLANUS

Lichen planus is a common inflammatory autoimmune condition that commonly affects the skin and mucous membranes. Ocular involvement is rare, but isolated conjunctival lichen planus is a rare cause of cicatricial conjunctivitis. In this case report, Muñoz et al describe a 79-year-old man with chronic refractory keratoconjunctivitis in the absence of any other skin or mucosal lesions. Biopsy specimens analyzed under direct immunofluorescence revealed changes suggestive of lichen planus. The patient's clinical findings improved following treatment with oral corticosteroids and azathioprine, demonstrating how early anti-inflammatory treatment can avoid irreversible visual loss.

XANTHOMA DISSEMINATUM

Xanthoma disseminatum (XD) is a rare, benign condition in which lipid deposition occurs secondary to histiocyte proliferation resulting in cutaneous xanthomatous lesions in the flexural areas along with ocular, oral, pharyngeal, visceral, skeletal, and central nervous system involvement. No known trigger has been identified, and response to therapy is usually unsatisfactory. In this case series, Khezri et al report 8 cases of XD, 5 of which showed substantial improvement after administration of the purine nucleoside analogue 2-chlorodeoxyadenosine (2-CdA), which was previously reported to be useful in treating Langerhans cell histiocytosis. No serious toxic effects were noted, suggesting that 2-CdA may represent one of the first useful therapeutic options reported for XD.

ADALIMUMAB FOR TREATMENT OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS OF THE HANDS AND FEET

Moderate to severe chronic plaque psoriasis of the hands and feet occurs infrequently. Despite the relatively small body surface area involvement, this psoriasis subset has a disproportionately negative impact on quality of life. Treatment is often unsatisfactory. Topical therapies and phototherapy are sometimes ineffective, and systemic therapies may be limited by adverse effects. In this randomized, double-blind, placebo-controlled study, Leonardi et al demonstrate that adalimumab is efficacious in treating adults with moderate to severe chronic plaque psoriasis on the hands or feet. Lesions on the palms responded better than those on the soles, and nail involvement was noted to improve as well. Adalimumab was well tolerated and posed a low risk of serious adverse events.

CLINICAL CORRELATIONS WITH DERMATOMYOSITIS-SPECIFIC AUTOANTIBODIES IN ADULT JAPANESE PATIENTS WITH DERMATOMYOSITIS

Polymyositis (PM) and dermatomyositis (DM) represent a group of chronic inflammatory disorders characterized by myogenic changes and/or skin eruptions. A variety of diagnostic autoantibodies (Abs) are associated with clinically distinct subsets of PM and DM. Identification of these Abs is useful in defining clinically homogeneous patient subsets and predicting prognosis. In this retrospective study, Hamaguchi et al evaluate all currently available myositis Abs for patients with DM, focusing on 3 highly DM-specific Abs: anti–Mi-2 and the more recently described anti–155/140 and anti–CADM-140. These DM-specific Abs were mutually exclusive, and each defined a clinically distinct phenotype. Classifying patients with DM according to these Abs may guide the physician to focus on particular manifestations at higher risk.

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

373 Views
0 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs